Page last updated: 2024-09-04

febuxostat and Obesity

febuxostat has been researched along with Obesity in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (83.33)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Clebak, KT; Croad, JR; Morrison, A	1
D Hayashi, R; Fujishima, Y; Fukuda, S; Funahashi, T; Ichida, K; Imagawa, A; Kimura, T; Kita, S; Kozawa, J; Maeda, N; Matsuoka, TA; Nishizawa, H; Otsuki, M; Shimomura, I; Taniguchi, A; Yamaoka, M	1
Becker, MA; Hunt, BJ; Jackson, RL; MacDonald, PA	1
Flipo, RN; Patrikos, DK; Richette, P	1
Becker, MA; Espinoza, LR; Lademacher, C; Lloyd, E; MacDonald, P; Schumacher, HR; Wells, AF	1
Becker, MA; Chefo, S; Chohan, S; Jackson, RL; MacDonald, PA	1

Reviews

1 review(s) available for febuxostat and Obesity

Article	Year
Gout: Rapid Evidence Review. American family physician, 2020, 11-01, Volume: 102, Issue:9 Topics: Adrenal Cortex Hormones; Allopurinol; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Obesity; Risk Factors; Sex Factors; Uric Acid	2020

Trials

3 trial(s) available for febuxostat and Obesity

Article	Year
Diabetes and gout: efficacy and safety of febuxostat and allopurinol. Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Body Mass Index; Cohort Studies; Comorbidity; Diabetes Complications; Dose-Response Relationship, Drug; Enzyme Inhibitors; Febuxostat; Female; Gout; Gout Suppressants; Humans; Intention to Treat Analysis; Kidney; Lost to Follow-Up; Male; Middle Aged; Obesity; Patient Dropouts; Renal Insufficiency; Thiazoles; Xanthine Oxidase; Young Adult	2013
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis research & therapy, 2010, Volume: 12, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Comorbidity; Dose-Response Relationship, Drug; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperlipidemias; Hypertension; Hyperuricemia; Kidney Diseases; Male; Middle Aged; Obesity; Thiazoles; Treatment Outcome; United States; Uric Acid; Young Adult	2010
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol. Arthritis care & research, 2012, Volume: 64, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Illinois; Male; Metabolic Diseases; Middle Aged; Obesity; Retrospective Studies; Sex Factors; Thiazoles; Treatment Outcome; Uric Acid; Young Adult	2012

Other Studies

2 other study(ies) available for febuxostat and Obesity

Article	Year
Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient. Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:9 Topics: Adult; Arthritis, Gouty; Cytokines; Febuxostat; Gout Suppressants; Hand; Humans; Hyperuricemia; Knee Joint; Male; Obesity; Treatment Outcome	2017
Characteristics and management of gout patients in Europe: data from a large cohort of patients. European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:4 Topics: Adult; Allopurinol; Cohort Studies; Comorbidity; Cross-Sectional Studies; Europe; Febuxostat; Female; France; Gout; Gout Suppressants; Greece; Humans; Male; Middle Aged; Obesity; Patient Compliance; Thiazoles; Uric Acid	2015

Article

Year

Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient.

Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:9

Topics: Adult; Arthritis, Gouty; Cytokines; Febuxostat; Gout Suppressants; Hand; Humans; Hyperuricemia; Knee Joint; Male; Obesity; Treatment Outcome

2017

Characteristics and management of gout patients in Europe: data from a large cohort of patients.

European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:4

Topics: Adult; Allopurinol; Cohort Studies; Comorbidity; Cross-Sectional Studies; Europe; Febuxostat; Female; France; Gout; Gout Suppressants; Greece; Humans; Male; Middle Aged; Obesity; Patient Compliance; Thiazoles; Uric Acid

2015